PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-2.71%
Negative net income growth while MCHP stands at 75.31%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-36.15%
Both reduce yoy D&A, with MCHP at -4.07%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-88.89%
Negative yoy deferred tax while MCHP stands at 235.31%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-24.31%
Both reduce yoy usage, with MCHP at -4545.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
194.12%
Inventory growth well above MCHP's 118.11%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
-36.60%
Both reduce yoy usage, with MCHP at -4414.08%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
1215.38%
Some yoy increase while MCHP is negative at -0.25%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-7.05%
Both yoy CFO lines are negative, with MCHP at -32.82%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-19.08%
Negative yoy CapEx while MCHP is 44.37%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1300.00%
Negative yoy acquisition while MCHP stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
58.67%
Some yoy expansion while MCHP is negative at -116.30%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
50.15%
At 50-75% of MCHP's 83.10%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
-100.00%
We reduce yoy other investing while MCHP is 12.31%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
259.57%
We have mild expansions while MCHP is negative at -186.87%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-59.64%
Negative yoy issuance while MCHP is 186.59%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-33.29%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.